UNICANCER
101 Rue De Tolbiac – Paris – 75013
VAT: nan
nan
Complicit EU Projects
Within the Horizon 2020 (2014-2020) framework, UNICANCER has received € 2,974,437.0 for its participation in a total of 1 project(s) with a total cost of € 12,498,983.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2018-01-01 | 755394 | MyPeBS | mortality · breast cancer | 2026-06-30 | coordinator | € 2,974,437.0 | € 12,498,983 | 1 | 31 | CORDIS ↪ |
Within the Horizon Europe (2021-2027) framework, UNICANCER has received € 1,131,375.0 for its participation in a total of 2 project(s) with a total cost of € 13,998,769.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-01 | 101136953 | DEFINITIVE | genetics · breast cancer | 2028-11-30 | participant | € 812,000.0 | € 7,999,930 | 1 | 18 | CORDIS ↪ |
| 2023-04-01 | 101104684 | PragmaTIL | oncology · health economics · cells technologies | 2028-03-31 | participant | € 319,375.0 | € 5,998,839 | 1 | 13 | CORDIS ↪ |
UNICANCER did not participate in FP7 (2007-2013).